Statistics

Total Visits

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)63

Select a period of time:

Number of views in the range

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)30

Views

Views
June 20250
July 202520
August 20251
September 20252
October 20251
November 20256
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil10
United States9
Argentina1
Dominican Republic1
Ecuador1
Egypt1
Ethiopia1
United Kingdom1
Kenya1
Tunisia1
 

Top cities views

Views
Al Mansurah1
Araçatuba1
Ashburn1
Awasa1
Blumenau1
Campo Grande1
Chimbas1
Criciúma1
Dallas1
East London1